xLabel	specimenDescriptorFill	boxSampleCount	geneEnsemblId	geneSymbol	pmtl	dataset	disease	gtexTissueSubgroup	efo	mondo	gtexTissueSubgroupUberon	tpmMean	tpmSd	tpmMin	tpm25thPercentile	tpmMedian	tpm75thPercentile	tpmMax
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 538)	Pediatric Primary Tumors	538	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		50.67	84.33	0	0.14	0.76	80.35	484.67
Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 168)	Pediatric Primary Tumors	168	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		3.5	7.19	0	0.48	1.19	3.28	67.01
Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 43)	Pediatric Primary Tumors	43	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Adamantinomatous Craniopharyngioma		EFO_1000069	MONDO_0002787		0.34	0.85	0	0.05	0.12	0.23	4.26
Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 45)	Pediatric Primary Tumors	45	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Atypical Teratoid Rhabdoid Tumor		EFO_1002008	MONDO_0020560		0.19	0.32	0	0.02	0.07	0.19	1.72
Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)	Pediatric Primary Tumors	5	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Chordoma		MONDO_0008978	MONDO_0008978		0.41	0.57	0	0.03	0.23	0.42	1.38
Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)	Pediatric Primary Tumors	10	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Choroid plexus carcinoma		MONDO_0016718	MONDO_0016718		0.11	0.11	0	0.03	0.06	0.15	0.3
Choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 23)	Pediatric Primary Tumors	23	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Choroid plexus papilloma		EFO_1000177	MONDO_0009837		0.13	0.2	0	0.03	0.05	0.12	0.87
Clear cell sarcoma of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 13)	Pediatric Primary Tumors	13	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Clear cell sarcoma of the kidney		EFO_0000350	MONDO_0005006		0.01	0.01	0	0	0	0.02	0.03
CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 12)	Pediatric Primary Tumors	12	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	CNS Embryonal tumor		EFO_0005784	MONDO_0018843		0.7	1.06	0.05	0.12	0.16	0.76	3.47
Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 13)	Pediatric Primary Tumors	13	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Craniopharyngioma		EFO_1000209	MONDO_0002787		0.27	0.26	0	0.14	0.16	0.3	0.8
Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 22)	Pediatric Primary Tumors	22	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse hemispheric glioma		MONDO_0016680	MONDO_0016680		0.37	1.25	0	0.02	0.06	0.16	5.96
Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse intrinsic pontine glioma		EFO_1000026	MONDO_0006033		0.27	0.15	0.05	0.24	0.32	0.36	0.37
Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)	Pediatric Primary Tumors	116	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Diffuse midline glioma		EFO_1000026	MONDO_0006033		0.38	0.45	0	0.1	0.29	0.48	3.2
Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)	Pediatric Primary Tumors	31	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Dysembryoplastic neuroepithelial tumor		EFO_0005551	MONDO_0005505		0.2	0.19	0.03	0.07	0.14	0.22	0.86
Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)	Pediatric Primary Tumors	3	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Embryonal tumor with multilayer rosettes		MONDO_0016715	MONDO_0016715		0.11	0.09	0.01	0.08	0.14	0.16	0.18
Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)	Pediatric Primary Tumors	116	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ependymoma		EFO_1000028	MONDO_0016698		0.15	0.29	0	0.03	0.08	0.17	2.68
Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)	Pediatric Primary Tumors	10	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ewing sarcoma		EFO_0000174	MONDO_0012817		0.14	0.11	0.01	0.04	0.12	0.25	0.27
Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 64)	Pediatric Primary Tumors	64	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Ganglioglioma		EFO_0003094	MONDO_0016733		0.22	0.43	0	0.06	0.1	0.21	3.3
Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 44)	Pediatric Primary Tumors	44	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		1.2	2.13	0.01	0.16	0.3	1.08	10.76
Ganglioneuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 25)	Pediatric Primary Tumors	25	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	GMKF	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		1.17	1.89	0.02	0.13	0.3	1.1	8.4
Ganglioneuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 20)	Pediatric Primary Tumors	20	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		1.22	2.39	0.11	0.2	0.36	0.99	10.76
Ganglioneuroma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 3)	Pediatric Primary Tumors	3	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Ganglioneuroma		EFO_0000500	MONDO_0005033		0.73	0.73	0.09	0.33	0.58	1.05	1.52
Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 8)	Pediatric Primary Tumors	8	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Germinoma		MONDO_0020580	MONDO_0020580		4.33	5.49	0.21	1.03	2.94	4.79	17.11
Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 17)	Pediatric Primary Tumors	17	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Glial-neuronal tumor		MONDO_0016729	MONDO_0016729		0.16	0.17	0	0.05	0.08	0.23	0.59
Glioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)	Pediatric Primary Tumors	3	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Glioblastoma		MONDO_0018177	MONDO_0018177		0.11	0.17	0.01	0.01	0.01	0.16	0.31
Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Hemangioblastoma		MONDO_0016748	MONDO_0016748		0.21	0.16	0.06	0.07	0.21	0.34	0.36
High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 125)	Pediatric Primary Tumors	125	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	High-grade glioma		MONDO_0100342	MONDO_0100342		0.25	0.44	0	0.06	0.12	0.33	4.19
Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)	Pediatric Primary Tumors	6	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Infant-type hemispheric glioma		EFO_0005543	MONDO_0014695		0.07	0.07	0	0.02	0.04	0.11	0.18
Langerhans Cell histiocytosis  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)	Pediatric Primary Tumors	5	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Langerhans Cell histiocytosis		EFO_1000318	MONDO_0018310		0.39	0.37	0.12	0.17	0.22	0.42	1.01
Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 334)	Pediatric Primary Tumors	334	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Low-grade glioma		MONDO_0021637	MONDO_0021637		0.17	0.2	0	0.06	0.11	0.2	1.67
Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 206)	Pediatric Primary Tumors	206	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Medulloblastoma		EFO_0002939	MONDO_0007959		0.3	0.47	0	0.03	0.1	0.38	3.06
Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)	Pediatric Primary Tumors	31	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Meningioma		MONDO_0016642	MONDO_0016642		0.17	0.21	0	0.06	0.1	0.16	0.83
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 304)	Pediatric Primary Tumors	304	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		2.27	6.62	0	0.09	0.32	1.15	57.88
Neuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 183)	Pediatric Primary Tumors	183	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	GMKF	Neuroblastoma		EFO_0000621	MONDO_0005072		1.38	3.62	0	0.07	0.27	0.88	32.7
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 129)	Pediatric Primary Tumors	129	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		3.56	9.2	0	0.12	0.44	1.93	57.88
Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 13)	Pediatric Primary Tumors	13	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Neurofibroma/Plexiform		EFO_0000658	MONDO_0003304		0.2	0.21	0	0.07	0.14	0.32	0.75
Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)	Pediatric Primary Tumors	4	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Non-germinomatous germ cell tumor		MONDO_0020580	MONDO_0020580		0.5	0.44	0.12	0.14	0.44	0.81	0.99
Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 36)	Pediatric Primary Tumors	36	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Oligodendroglioma		EFO_0000632	MONDO_0016695		0.06	0.08	0	0.02	0.04	0.07	0.5
Osteosarcoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 87)	Pediatric Primary Tumors	87	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Osteosarcoma		EFO_0000637	MONDO_0009807		0.42	0.71	0	0.05	0.18	0.52	5.46
Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 7)	Pediatric Primary Tumors	7	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Pilocytic astrocytoma		MONDO_0016691	MONDO_0016691		0.28	0.2	0	0.17	0.29	0.36	0.63
Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)	Pediatric Primary Tumors	10	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Pineoblastoma		EFO_1000475	MONDO_0016722		1.47	1.69	0.02	0.22	0.84	2.32	5.28
Pleomorphic xanthoastrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)	Pediatric Primary Tumors	3	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Pleomorphic xanthoastrocytoma		MONDO_0016690	MONDO_0016690		0.12	0.1	0.03	0.07	0.12	0.17	0.22
Rhabdoid tumor of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 64)	Pediatric Primary Tumors	64	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Rhabdoid tumor of the kidney		EFO_1000512	MONDO_0002729		0.63	3.87	0	0.03	0.07	0.15	31.02
Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 7)	Pediatric Primary Tumors	7	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Sarcoma		EFO_0000691	MONDO_0005089		0.39	0.48	0	0.04	0.26	0.6	1.2
Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 23)	Pediatric Primary Tumors	23	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Schwannoma		EFO_0000693	MONDO_0002546		0.19	0.17	0.01	0.06	0.14	0.29	0.62
Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 13)	Pediatric Primary Tumors	13	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Subependymal Giant Cell Astrocytoma		MONDO_0016693	MONDO_0016693		0.09	0.11	0	0.04	0.06	0.08	0.38
Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)	Pediatric Primary Tumors	6	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	PBTA	Teratoma		MONDO_0002601	MONDO_0002601		0.4	0.49	0.04	0.07	0.17	0.54	1.29
Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 124)	Pediatric Primary Tumors	124	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TARGET	Wilms tumor		MONDO_0006058	MONDO_0006058		8.1	12.53	0	0.74	2.88	10.06	76.29
Acute Myeloid Leukemia  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 147)	TCGA Primary Tumors	147	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		11.76	21.14	0.91	4.34	6.07	11.26	209.97
Adrenocortical Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 77)	TCGA Primary Tumors	77	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Adrenocortical Carcinoma		EFO_1000796	MONDO_0006639		1.57	3.17	0	0.18	0.49	1.3	19.97
Bladder Urothelial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 405)	TCGA Primary Tumors	405	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Bladder Urothelial Carcinoma		EFO_0006544	MONDO_0005611		3.85	18.98	0	0.18	0.53	1.77	286.96
Breast Invasive Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 1088)	TCGA Primary Tumors	1088	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Breast Invasive Carcinoma		EFO_1000307	MONDO_0006256		2.69	9	0	0.2	0.6	2.02	161.83
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 304)	TCGA Primary Tumors	304	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma		EFO_1000162	MONDO_0006143		1.84	2.79	0	0.43	0.97	2.12	31.16
Cholangiocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 35)	TCGA Primary Tumors	35	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cholangiocarcinoma		EFO_0005221	MONDO_0019087		13.72	69	0	0.08	0.22	0.87	409.32
Chromophobe renal cell carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 65)	TCGA Primary Tumors	65	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Chromophobe renal cell carcinoma		EFO_0000335	MONDO_0017885		0.22	0.5	0	0.03	0.1	0.19	3.68
Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 288)	TCGA Primary Tumors	288	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Colon Adenocarcinoma		EFO_1001949	MONDO_0002271		2.01	4.42	0	0.41	1.02	2	52.11
Cutaneous Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 102)	TCGA Primary Tumors	102	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Cutaneous Melanoma		EFO_0000389	MONDO_0005012		1.06	3.35	0	0.07	0.2	0.57	30.65
Esophageal Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 158)	TCGA Primary Tumors	158	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Esophageal Carcinoma		EFO_0002916	MONDO_0019086		2.14	3	0	0.38	1	2.32	19.79
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 152)	TCGA Primary Tumors	152	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		0.47	0.33	0	0.25	0.39	0.58	1.93
Head and Neck Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Head and Neck Squamous Cell Carcinoma		EFO_0000181	MONDO_0010150		2.14	6.02	0	0.21	0.65	1.64	75.82
Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 369)	TCGA Primary Tumors	369	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Hepatocellular Carcinoma		EFO_0000182	MONDO_0007256		0.99	4.65	0	0.07	0.22	0.58	82.94
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 507)	TCGA Primary Tumors	507	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		0.36	0.61	0	0.16	0.25	0.44	12.57
Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 510)	TCGA Primary Tumors	510	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Adenocarcinoma		EFO_0000571	MONDO_0005061		5.49	7.17	0	1.33	3.12	6.84	52.66
Lung Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)	TCGA Primary Tumors	498	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lung Squamous Cell Carcinoma		EFO_0000708	MONDO_0005097		5.29	18.88	0.02	1.01	2.68	5.46	399.95
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 47)	TCGA Primary Tumors	47	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma		EFO_0000403	MONDO_0018905		356.14	200.18	14.78	216.97	319.35	471.48	873.95
Mesothelioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 86)	TCGA Primary Tumors	86	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Mesothelioma		EFO_0000588	MONDO_0005065		3.93	13.16	0.02	0.27	0.57	2.55	90.33
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		1.57	2.04	0	0.48	0.97	1.81	22.42
Pancreatic Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pancreatic Adenocarcinoma		EFO_1000044	MONDO_0006047		7.57	25.17	0	0.37	0.93	3.87	237.82
Pheochromocytoma and Paraganglioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)	TCGA Primary Tumors	177	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Pheochromocytoma and Paraganglioma		EFO_0020005	MONDO_0035540		0.25	0.51	0	0.05	0.1	0.22	4.87
Prostate Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 494)	TCGA Primary Tumors	494	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Prostate Adenocarcinoma		EFO_0000673	MONDO_0005082		1.21	3.72	0	0.15	0.32	0.85	56.62
Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 92)	TCGA Primary Tumors	92	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Rectum Adenocarcinoma		EFO_0005631	MONDO_0002169		1.35	1.88	0	0.46	0.92	1.57	12.55
Renal Clear Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 527)	TCGA Primary Tumors	527	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Clear Cell Carcinoma		EFO_0000349	MONDO_0005005		0.79	1.68	0	0.19	0.35	0.71	24.32
Renal Papillary Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 286)	TCGA Primary Tumors	286	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Renal Papillary Cell Carcinoma		EFO_0000640	MONDO_0017884		1.33	10.83	0	0.08	0.23	0.48	180.62
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 258)	TCGA Primary Tumors	258	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		1.58	7.41	0	0.1	0.25	0.69	99.3
Stomach Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)	TCGA Primary Tumors	373	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Stomach Adenocarcinoma		EFO_0000503	MONDO_0005036		5.01	14.53	0.01	0.73	1.84	4.28	225.14
Testicular Germ Cell Tumor  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 148)	TCGA Primary Tumors	148	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Testicular Germ Cell Tumor		EFO_1000566	MONDO_0010108		10.77	15.82	0.29	3.35	5.93	10.73	106.78
Thymoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 118)	TCGA Primary Tumors	118	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thymoma		EFO_1000581	MONDO_0006456		6.07	13.74	0.05	0.78	2.08	5.23	107.39
Thyroid Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 501)	TCGA Primary Tumors	501	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Thyroid Carcinoma		EFO_0002892	MONDO_0015075		2.23	8.01	0	0.08	0.21	0.92	107.79
Uterine Carcinosarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 56)	TCGA Primary Tumors	56	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Carcinosarcoma		EFO_1000613	MONDO_0006485		2.14	5.32	0	0.14	0.52	1.31	28.51
Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 178)	TCGA Primary Tumors	178	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uterine Corpus Endometrial Carcinoma		EFO_0007532	MONDO_0000553		2.26	3.23	0	0.42	1.03	2.57	23.29
Uveal Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 79)	TCGA Primary Tumors	79	ENSG00000177455	CD19	Relevant Molecular Target (PMTL version 3.1)	TCGA	Uveal Melanoma		EFO_1000616	MONDO_0006486		0.55	2.32	0	0.04	0.1	0.26	19.72